Search Results for “about:blank”




Data Brief: Naloxone Prescription in Response to the Opioid Epidemic

In response to the opioid epidemic, the Arkansas General Assembly passed Act 651 of 2021, which requires a co-prescription of naloxone in certain situations for a person who does not have an existing prescription. The law was preceded by Act 284 of 2017, which authorized pharmacists to order, dispense, and administer naloxone to individuals without a prescription under a state protocol.
Read More





ACHI Submits Public Comment on ARHOME Application

On Monday, July 12, ACHI submitted a public comment on Arkansas’s waiver application for Arkansas Health and Opportunity for ME, or ARHOME, the proposed overhaul of the state’s Medicaid expansion program known currently as Arkansas Works.
Read More

ACHI Public Comment on ARHOME Application

This document contains ACHI’s public comment on Arkansas’s waiver application for Arkansas Health and Opportunity for ME, or ARHOME, an overhaul of the state’s Medicaid expansion program. ACHI submitted the comment on July 12, 2021.
Read More

340B Drug Pricing Program: An Overview

The federal 340B Drug Pricing Program requires prescription drug manufacturers to provide drugs to certain healthcare organizations at heavily reduced prices as a condition of having their products covered by Medicaid.
Read More